Psychotropic-related hip fractures: Meta-analysis of first- generation and second-generation antidepressant and antipsychotic drugs;Fracturas de cadera relacionadas con agentes psicotrópicos: Un metaanálisis de fármacos antidepresores y antipsicóticos de primera generación y de segunda generación

Annals of Pharmacotherapy

Volumn 46, Issue 7-8, 2012, Pages 917-928

  Oderda, Lynda H ^a   Young, Jason R ^a   Asche, Carl V ^b   Pepper, Ginette A ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Age; Antidepressants; Antipsychotics; Hip fractures

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MIRTAZAPINE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG INDUCED DISEASE; EMBASE; HIP FRACTURE; HUMAN; MEDLINE; PRIORITY JOURNAL;

ACCIDENTAL FALLS; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; HIP FRACTURES; HUMANS; ODDS RATIO; RISK;

EID: 84864781580     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q589     Document Type: Article

References (55)

1. Kannus P, Parkkari J, Koskinen S, et al. Fall-induced injuries and deaths among older adults. J Am Med Assoc 1999;281:1895-1899.
2. Centers for Disease Control and Prevention (CDC) 2011. Falls among older adults: an overview. www.cdc.gov/homeandrecreationalsafety/falls/adultfalls.html (accessed 2012 Jan 13).
3. American Geriatrics Society/British Geriatrics Society Clinical Practice Guideline for Prevention of Falls in Older Persons. American Geriatrics Society. www.americangeriatrics.org/health_care_professionals/clinical_practice/clinical_guidelines_recommendations/2010/ (accessed 2011 Aug 25).
4. Procyshyn RM, Honer WG, Wu TKY, et al. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients. J Clin Psychiatry 2010;71:566-73. doi: 10.4088/JCP.08m04912gre
5. Takkouche B, Montes-Martinez A, Gill SS, Etminan M. Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 2007;30:171-184.
6. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ 3rd. Psychotropic drug use and risk of hip fractures. N Engl J Med 1987;316: 363-369. doi: 10.1056/NEJM198702123160702
7. Bolton JM, Metge C, Lix L, Prior H, Sareen J, Leslie WD. Fracture riskfrom psychotropic medications: a population-based analysis. J Clin Psychopharmacol 2008;28:384-91. doi: 10.1097/JCP.0b013e31817d5943
8. Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporosis Int 2006; 17:807-816. doi: 10.1007/s00198-005-0065-y
9. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis, I. Psychotropic drugs. J Am Geriatr Soc 1999;47:30-39.
10. Cumming RG, Nevitt MC, Cummings SR. Epidemiology of hip fractures. Epidemiol Rev 1997;19:244-557.
11. Hugenholtz GW, Heerdink ER, van Staa TP, Nolan WA, Egberts AC. Risk of hip/femur fractures in patients using antipsychotics. Bone 2005; 37:864-70. doi: 10.1016/j.bone.2005.07.005
12. Magaziner J, Hawkes W, Hebel JR, et al. Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 2000;55:M498-507.
13. van den Brand MW, Pouwels S, Samson MM, et al. Use of anti-depressantsand the risk of fracture of the hip or femur. Osteoporos Int 2009; 20:1705-1713. doi: 10.1007/s00198-009-0849-6 [Erratum in Osteoporos Int 2009;20:1715].
14. Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc 2003;51:364-370.
15. Borgquist L, Lindelow G, Thorngren KG. Costs of hip fracture. Rehabilitation of 180 patients in primary health care. Acta Orthop Scand 1991; 62:39-48.
16. Parkkari J, Kannus P, Natri A, et al. Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 1999;65:183-187.
17. Avidan A, Fries B, James M, Szafara K, Wright G, Chervin R. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005;53:955-962. doi: 10.1111/j.1532-5415.2005.53304.x
18. Kolanowski A, Fick D, Waller J, Ahern F. Outcomes of antipsychotic drug use in community-dwelling elders with dementia. Arch Psych Nurs 2006;20:217-225. doi: 10.1016/j.apnu.2006.04.004
19. Haney E, Warden S, Bliziotes M. Effects of serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention, and management? Bone 2010;46:13-17. doi: 10.1016/j.bone.2009.07.083
20. Sleeper R, Bond CA, Rojas-Fernandez C. Psychotropic drugs and falls: new evidence pertaining to serotonin reuptake inhibitors. Pharmacotherapy 2000;20:308-317.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-560. doi: 10.1136/bmj.327.7414.557
22. Jalbert JJ, Eaton CB, Miller SC, Lapane KL. Antipsychotic use and risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc 2010;11:120-127. doi: 10.1016/j.jamda.2009.10.001
23. Pouwels S, van Staa TP, Egberts AC, Leufkens HG, Cooper C, de Vries F. Antipsychotic use and the risk of hip/femur fracture: a populationbased case-control study. Osteoporos Int 2009;20:1499-1506. doi: 10.1007/s00198-008-0826-5
24. Liperoti R, Onder G, Lapane KL, et al. Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. J Clin Psychiatry 2007;68:929-934.
25. Wang P, Bohn R, Glynn R, Mogun H, Avom J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc 2001;49:1685-1690.
26. Guo Z, Wills P, Viitanen M, Fastbom J, Winblad B. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community- based prospective study. Am J Epidemiol 1998;148:887-892.
27. Lichtenstein M, Giffin M, Cornell J, Malcom E, Ray WA. Risk factors for hip fractures occurring in the hospital. Am J Epidemiol 1994;14:830-838.
28. Cumming RG, Klineberg RJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 1993;158:414-417.
29. Chang C, Wu E, Chang I, Lin KM. Benzodiazepine and risk of hip fractures in older people: a nested case-control study in Taiwan. Am J Geriatr Psychiatry 2008;16:686-692. doi: 10.1097/JGP.0b013e31817c6a99
30. Ensrud KE, Blackwell T, Mangione CM, et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 2003;163:949-957. doi: 10.1001/archinte.163.8.949
31. Hubbard R, Farrington P, Smith C, Smeeth L, Tattersfield A. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 2003;158:77-84.
32. Jacqmin-Gadda H, Fourrier A, Commenges D, Dartigues JF. Risk factors for fractures in the elderly. Epidemiology 1998;9:417-423.
33. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998;351:1303-1307.
34. Johansson C, Skoog I. A population-based study on the association between dementia and hip fractures in 85-year olds. Aging (Milano) 1996;8:189-196.
35. Ray W, Griffin M, Malcolm E. Cyclic antidepressants and the risk of hip fracture. Arch Intern Med 1991;151:754-756.
36. Jensen J, Nielsen L, Lyhne N, Hallas J, Brosen K, Gram LF. Drugs and femoral neck fracture: a case-control study. J Intern Med 1991;229:29-33.
37. Zhang Z, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 1998;280: 1690-1691.
38. Deeks JJ, Higgins JPT, Altman DG. Analysing and presenting results. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions 4.2.6 [updated September 2006]; section 8. The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
39. Kannus P, Parkkari J, Sievanen H, Heinonen A, Vuori I, Jarvinen M. Epidemiology of hip fractures. Bone 1996;18(suppl 1):57S-63S.
40. Green C, Molony D, Fitzpatrick C, O'Rourke K. Age-specific incidence of hip fracture in the elderly: a healthy decline. Surgeon 2010;8:310-313. doi: 10.1016/j.surge.2010.05.008
41. Ahlborg HG, Rosengren BE, Jarvinen TLN, et al. Prevalence of osteoporosis and incidence of hip fracture in women-secular trends over 30 years. BMC Musculoskeletal Disorders. www.biomedcentral.com/1471-2474/11/48 (accessed 2011 Dec 4). doi: 10.1186/1471-2474-11-48
42. Wang MC, Bushman BJ. Using the normal quantile plot to explore metaanalytic data set. Psychological Methods 1998;3:46-54. doi: 10.1037/1082-989X.3.1.46
43. Schneider L, Dagerman K, Insel P. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebocontrolled trials. Am J Geriatr Psychiatry 2006;14:191-210. doi: 10.1097/01.JGP.0000200589.01396.6d
44. O'Donnell JF, Shelton RD. Drug therapy of depression and anxiety disorders. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011. www.accessmedicine.com/content.aspx?aID=16663059 (accessed 2011 Dec 8).
45. Gill SS, Bronskill SE, Normand ST, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007;146:775-786.
46. Kales HC, Valenstein M, Kim HM, et al. Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications. Am J Psychiatry 2007;164:1568-1576. doi: 10.1176/appi.ajp.2007.06101710
47. Brainsky A, Glick H, Lydick E, et al. The economic cost of hip fractures in community-dwelling older adults: a prospective study. J Am Geriatr Soc 1997;45:281-287
48. Affi M. Falls and depression in the elderly population. Saudi Med J 2006; 27:128-129.
49. Graafmans WC, Ooms ME, Hofstee HM, Bezemer PD, Bouter LM, Lips P. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 1996;143:1129-1136.
50. Kerse N, Flicker L, Pfaff J, et al. Falls, depression and antidepressants in later life: a large primary care appraisal. PLoS ONE 2008;3:e2423. doi: 10.1371/journal.pone.0002423
51. Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci 2005;60:622-626.
52. Whooley MA, Kip KE, Cauley JA, Ensrud KE, Nevitt MC, Browner WS. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999;159:484-490.
53. Spangler L, Scholes D, Brunner RL, et al. Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 2008;23:567-574. doi: 10.1007/s11606-008-0525-0
54. Bolbecker A, Hong S, Kent J, Klaunig M, O'Donnell B, Hetrick W. Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. PLoS ONE 2011;6:e19824. doi: 10.1371/journal.pone.0019824
55. Royal S, Smeaton L, Avery AJ, Hurwitz B, Sheikh A. Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Qual Saf Health Care 2006;15:23-31. doi: 10.1136/qshc.2004.012153